期刊
CELL REPORTS
卷 35, 期 11, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2021.109255
关键词
-
类别
资金
- European Research Council [818858]
- Binational Science Foundation [2015289]
- NIH/NHLBI [R35HL140017]
- Minerva Foundation [712610]
- H&M Kimmel Inst. for Stem Cell Research
- Estate of Emile Mimran (SABRA program)
- Weizmann Institute of Science
- European Research Council (ERC) [818858] Funding Source: European Research Council (ERC)
The study reveals that controlling cell cycle progression can enhance endothelial cell sprouting, raising important questions about the use of cell cycle inhibitors in pathological angiogenesis and lymphangiogenesis.
The formation of new vessels requires a tight synchronization between proliferation, differentiation, and sprouting. However, how these processes are differentially activated, often by neighboring endothelial cells (ECs), remains unclear. Here, we identify cell cycle progression as a regulator of EC sprouting and differentiation. Using transgenic zebrafish illuminating cell cycle stages, we show that venous and lymphatic precursors sprout from the cardinal vein exclusively in G1 and reveal that cell-cycle arrest is induced in these ECs by overexpression of p53 and the cyclin-dependent kinase (CDK) inhibitors p27 and p21. We further demonstrate that, in vivo, forcing G1 cell-cycle arrest results in enhanced vascular sprouting. Mechanistically, we identify the mitogenic VEGFC/VEGFR3/ERK axis as a direct inducer of cell-cycle arrest in ECs and characterize the cascade of events that render ``sprouting-competent'' ECs. Overall, our results uncover a mechanism whereby mitogen-controlled cell-cycle arrest boosts sprouting, raising important questions about the use of cell cycle inhibitors in pathological angiogenesis and lymphangiogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据